Dianthus Therapeutics, Inc. /DE/ Annual Share-based Payment Arrangement, Expense in USD from 2016 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Dianthus Therapeutics, Inc. /DE/ quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2016 to 2024.
  • Dianthus Therapeutics, Inc. /DE/ Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $3.92M, a 440% increase year-over-year.
  • Dianthus Therapeutics, Inc. /DE/ Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $12.9M, a 345% increase year-over-year.
  • Dianthus Therapeutics, Inc. /DE/ annual Share-based Payment Arrangement, Expense for 2024 was $12.9M, a 345% increase from 2023.
  • Dianthus Therapeutics, Inc. /DE/ annual Share-based Payment Arrangement, Expense for 2023 was $2.9M, a 91% increase from 2022.
  • Dianthus Therapeutics, Inc. /DE/ annual Share-based Payment Arrangement, Expense for 2022 was $1.52M, a 2310% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $12.9M +$9.99M +345% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-11
2023 $2.9M +$1.38M +91% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-11
2022 $1.52M +$1.46M +2310% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 $63K -$9.88M -99.4% Jan 1, 2021 Dec 31, 2021 8-K 2023-12-21
2020 $9.94M -$60K -0.6% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-08
2019 $10M -$702K -6.56% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-03
2018 $10.7M +$8.44M +374% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-03
2017 $2.26M +$1.6M +241% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-03
2016 $662K Jan 1, 2016 Dec 31, 2016 10-K 2019-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.